Formulation Development Outsourcing Market by Service, Dosage Form, Application - Global Forecast 2025-2030- Product Image

Sale

Formulation Development Outsourcing Market by Service, Dosage Form, Application - Global Forecast 2025-2030

Report
183 Pages
October 2024
Region: Global
360iResearch™
ID: 5666113

UP TO €681EUR$697USD£568GBP OFF until Dec 31^st 2024

The Formulation Development Outsourcing Market grew from USD 40.01 billion in 2023 to USD 43.76 billion in 2024. It is expected to continue growing at a CAGR of 9.85%, reaching USD 77.26 billion by 2030.

The scope and definition of formulation development outsourcing encompass the delegation of pharmaceutical formulation tasks to specialized external entities, aimed at enhancing drug development efficiency and reducing time-to-market. This practice is essential due to the increasing complexity of drug formulations and the need for specialized expertise and cutting-edge technology, which many pharmaceutical companies may lack in-house. The application spans across various drug types, including oral, injectable, and topical formulations, with end-use cases predominantly seen in pharmaceutical companies, biotechnology firms, and research institutions. Market growth is driven by factors such as rising drug development costs, stringent regulatory requirements, and the need for rapid product commercialization. Moreover, the increasing prevalence of chronic diseases further necessitates efficient formulation development to meet rising therapeutic demands. Opportunities lie in leveraging advanced technologies such as AI-driven predictive modeling, continuous manufacturing processes, and personalized medicine approaches. Companies can capitalize on these by investing in strategic partnerships and research collaborations to enhance their technological and knowledge base. However, the market faces challenges like intellectual property concerns, high dependency on third-party providers, and variability in quality standards across different outsourcing partners, which may hinder growth. Innovation and research should focus on sustainable formulations, novel delivery systems, and improving biopharmaceutical properties to enhance therapeutic efficacy and patient compliance. Continuous advancements in nanotechnology and bioconjugation could also unlock new potential in this domain. The market is characterized by a dynamic and competitive landscape, with numerous players vying for market share, thus necessitating constant innovation and strategic agility. Businesses that effectively navigate these challenges - while addressing regulatory and quality compliance - can anticipate sustainable growth and leadership in this ever-evolving market.

Understanding Market Dynamics in the Formulation Development Outsourcing Market

The Formulation Development Outsourcing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing demand for new drugs owing to the high burden of chronic and infectious diseases
- Huge focus on developing poorly water-soluble compounds to improve bioavailability
- Rapidly growing number of clinical studies globally
Market Restraints
- High cost of formulation development outsourcing
Market Opportunities
- Increasing R&D spending to improve the formulation development outsourcing services
- Development of new technologies for formulation development
Market Challenges
- Quality control complexities associated with formulation development outsourcing

Exploring Porter’s Five Forces for the Formulation Development Outsourcing Market

Porter’s Five Forces framework further strengthens the insights of the Formulation Development Outsourcing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Formulation Development Outsourcing Market

External macro-environmental factors deeply influence the performance of the Formulation Development Outsourcing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Formulation Development Outsourcing Market

The Formulation Development Outsourcing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Formulation Development Outsourcing Market

The Formulation Development Outsourcing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Formulation Development Outsourcing Market

The Formulation Development Outsourcing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Formulation Development Outsourcing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aizant Drug Research Solutions Private Limited, Cambrex Corporation, Catalent Inc., Emergent Biosolutions Inc., Eurofins Scientific SE, Intertek Group PLC, Jubilant Pharmova Limited, Lonza Group AG, Piramal Group, Quotient Sciences Limited, Recipharm AB, Samsung Biologics Co., Ltd., SGS S.A., Siegfried AG, and Syngene International Limited.

Market Segmentation & Coverage

This research report categorizes the Formulation Development Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Service
- Formulation Optimization
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- Pre-formulation Services
  - Analytical Services
  - Discovery & Preclinical Services
Dosage Form
- Injectable
- Oral
- Topical
Application
- Cardiovascular
- Genetic Disorders
- Infectious Diseases
- Neurology
- Oncology
- Respiratory

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for new drugs owing to the high burden of chronic and infectious diseases
5.1.1.2. Huge focus on developing poorly water-soluble compounds to improve bioavailability
5.1.1.3. Rapidly growing number of clinical studies globally
5.1.2. Restraints
5.1.2.1. High cost of formulation development outsourcing
5.1.3. Opportunities
5.1.3.1. Increasing R&D spending to improve the formulation development outsourcing services
5.1.3.2. Development of new technologies for formulation development
5.1.4. Challenges
5.1.4.1. Quality control complexities associated with formulation development outsourcing
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Formulation Development Outsourcing Market, by Service

6.1. Introduction
6.2. Formulation Optimization
6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV
6.3. Pre-formulation Services
6.3.1. Analytical Services
6.3.2. Discovery & Preclinical Services

7. Formulation Development Outsourcing Market, by Dosage Form

7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Topical

8. Formulation Development Outsourcing Market, by Application

8.1. Introduction
8.2. Cardiovascular
8.3. Genetic Disorders
8.4. Infectious Diseases
8.5. Neurology
8.6. Oncology
8.7. Respiratory

9. Americas Formulation Development Outsourcing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Formulation Development Outsourcing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Formulation Development Outsourcing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. FORMULATION DEVELOPMENT OUTSOURCING MARKET DYNAMICS
TABLE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DISCOVERY & PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 46. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 48. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 49. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 53. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 54. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 73. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 74. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 75. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 78. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 79. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 80. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 89. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 90. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 118. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 119. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 120. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 121. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 135. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 136. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 137. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 141. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 142. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 146. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 147. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 151. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 156. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 157. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 164. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 165. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 166. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 167. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 179. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 181. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 182. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 184. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 185. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 186. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 189. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 191. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 192. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 211. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 212. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 226. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 227. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 239. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Formulation Development Outsourcing Market, which are profiled in this report, include:

AbbVie Inc.
Aizant Drug Research Solutions Private Limited
Cambrex Corporation
Catalent Inc.
Emergent Biosolutions Inc.
Eurofins Scientific SE
Intertek Group PLC
Jubilant Pharmova Limited
Lonza Group AG
Piramal Group
Quotient Sciences Limited
Recipharm AB
Samsung Biologics Co., Ltd.
SGS S.A.
Siegfried AG
Syngene International Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	183
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 43.76 Billion
Forecasted Market Value ( USD ) by 2030	$ 77.26 Billion
Compound Annual Growth Rate	9.8%
Regions Covered	Global
No. of Companies Mentioned	16

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3464EUR$3,545USD£2,892GBP €3849EUR$3,939USD£3,213GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6128EUR$6,272USD£5,116GBP €6809EUR$6,969USD£5,684GBP

Understanding Market Dynamics in the Formulation Development Outsourcing Market

Exploring Porter’s Five Forces for the Formulation Development Outsourcing Market

Applying PESTLE Analysis to the Formulation Development Outsourcing Market

Analyzing Market Share in the Formulation Development Outsourcing Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Formulation Development Outsourcing Market

Strategic Recommendations for Success in the Formulation Development Outsourcing Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Formulation Development Outsourcing Market Report by Service, Dosage Form, Application, End User, and Region 2024-2032

Chemistry, Manufacturing And Control Services Outsourcing Market Size, Share & Trends Analysis Report By Type (API, Finished Drug Formulation, Medical Devices), By Service, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Formulation Development Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Formulation Development Outsourcing Global Market Report 2024

Pharmaceutical Manufacturing Market by Formulation, Drug Development Type, Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2025-2030

About the Formulation Development Market